Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received one dose of Twinrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received first dose of Twinrix on 19-SEP-2024), Heplisav b (received first dose of Heplisav b on 19-SEP-2024) and Heplisav b (received second dose of Heplisav b on 19-OCT-2024). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: received one dose of Twinrix ). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-MAR-2025 and 22-MAR-2025 The pharmacist reported that a patient received one dose of Twinrix and one of Heplisav-B and a second dose of Heplisav-B on. The pharmacist provided the lot number and expiration date of one of the Heplisav-B vaccines administered was 944915 and 19th September 2026. That was the only vaccine from which she had that kind of information. The Vaccine Administration Facility was the same as Primary Reporter. Till the time of reporting the patient did not receive the second dose of Twinrix which led to incomplete course of vaccination.